These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3976396)

  • 1. Efficacy of Metronidazole in experimental Bacteroides fragilis otitis media.
    Thore M; Sjöberg W; Burman LG; Holm SE
    Acta Otolaryngol; 1985; 99(1-2):60-6. PubMed ID: 3976396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levofloxacin plus metronidazole administered once daily versus moxifloxacin monotherapy against a mixed infection of Escherichia coli and Bacteroides fragilis in an in vitro pharmacodynamic model.
    Hermsen ED; Hovde LB; Sprandel KA; Rodvold KA; Rotschafer JC
    Antimicrob Agents Chemother; 2005 Feb; 49(2):685-9. PubMed ID: 15673752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metronidazole treatment of Bacteroides fragilis infections.
    Melo JC; Raff MJ; Wunderlich HF; Chun CH; Summersgill JT; Varghese R
    Am J Med Sci; 1980; 280(3):143-9. PubMed ID: 7457495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Metronidazole in the treatment of anaerobic infection].
    Katranushkova N
    Khirurgiia (Sofiia); 1983; 36(1):30-5. PubMed ID: 6137590
    [No Abstract]   [Full Text] [Related]  

  • 5. [Bacteriological and clinical studies on metronidazole in Bacteroides fragilis infections (author's transl)].
    Shimada K; Inamatsu T; Sato K
    Jpn J Antibiot; 1979 Feb; 32(2):191-4. PubMed ID: 439390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative antibacterial efficacy of clindamycin and metronidazole against Bacteroides fragilis in vitro and in experimentally infected mice.
    Dijkmans BA; Vaishnav J; Mattie H
    Chemotherapy; 1985; 31(4):297-303. PubMed ID: 4028873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacteroides fragilis-induced intra-abdominal abscess in an experimental model treated with telithromycin (HMR 3647).
    Thadepalli H; Chuah SK; Qazi S; Thadepalli F; Gollapudi SV
    Chemotherapy; 2001; 47(1):43-9. PubMed ID: 11125232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacteroides fragilis resistant to metronidazole after long-term therapy.
    Ingham HR; Eaton S; Venables CW; Adams PC
    Lancet; 1978 Jan; 1(8057):214. PubMed ID: 74641
    [No Abstract]   [Full Text] [Related]  

  • 9. Metronidazole resistant Bacteroides fragilis infection of a prosthetic hip joint.
    Hickey MM; Davies UM; Dave J; Vogler M; Wall RA
    J Infect; 1990 Mar; 20(2):129-33. PubMed ID: 2319145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of metronidazole on Escherichia coli in the presence of Bacteroides fragilis: an investigation in mice.
    Reznikov M; McDonald PJ
    Chemotherapy; 1983; 29(3):225-9. PubMed ID: 6347547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic efficacy and pharmacokinetic properties of rifampicin in a Bacteroides fragilis intra-abdominal abscess.
    Fu KP; Lasinski ER; Zoganas HC; Kimble EF; Konopka EA
    J Antimicrob Chemother; 1984 Dec; 14(6):633-40. PubMed ID: 6520063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of the effect of anti-anaerobic drugs in experimental Bacteroides fragilis infection in mice.
    Dijkmans BA; Mattie H; Hermans J; van Furth R
    J Antimicrob Chemother; 1984 Jan; 13(1):79-86. PubMed ID: 6365877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative efficacy and critical interval of antimicrobial agents in experimental infections involving bacteroides fragilis.
    Bartlett JG; Dezfulian M; Joiner K
    Arch Surg; 1983 Feb; 118(2):181-4. PubMed ID: 6849635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental otitis media in guinea pigs. Serum antibody response to Bacteroides fragilis, Propionibacterium acnes and Peptostreptococcus anaerobius upon challenge.
    Thore M
    Acta Otolaryngol Suppl; 1984; 414():143-6. PubMed ID: 6598260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteraemia due to Bacteroides fragilis with reduced susceptibility to metronidazole.
    Elsaghier AA; Brazier JS; James EA
    J Antimicrob Chemother; 2003 Jun; 51(6):1436-7. PubMed ID: 12746378
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic efficacy of moxifloxacin, a new quinolone, in the treatment of experimental intra-abdominal abscesses induced by Bacteroides fragilis in mice.
    Thadepalli H; Chuah SK; Gollapudi S
    Chemotherapy; 2004 Jun; 50(2):76-80. PubMed ID: 15211081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metronidazole single versus multiple daily dosing in serious intraabdominal/pelvic and diabetic foot infections.
    Wang S; Cunha BA; Hamid NS; Amato BM; Feuerman M; Malone B
    J Chemother; 2007 Aug; 19(4):410-6. PubMed ID: 17855185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of irradiated mice with polymicrobial infection caused by Bacteroides fragilis and Escherichia coli.
    Brook I; Ledney GD
    J Antimicrob Chemother; 1994 Feb; 33(2):243-52. PubMed ID: 8182005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppurative labyrinthitis caused by anaerobic bacteria.
    Egelund E; Bak-Pedersen K
    J Laryngol Otol; 1994 May; 108(5):413-4. PubMed ID: 8035121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacteroides fragilis meningitis in a premature infant successfully treated with metronidazole.
    Webber SA; Tuohy P
    Pediatr Infect Dis J; 1988 Dec; 7(12):886-7. PubMed ID: 3211633
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.